HB4721

Summary

A West Virginia bill adding FDA-approved crystalline polymorph psilocybin to the state's drug scheduling provisions has been filed for introduction. If enacted, scheduling provisions would define the legal status of this compound and affect whether and how it can be dispensed to patients in West Virginia.

More West Virginia Cannabis Bills

• SB906Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendationsPassed
• HB5260Relating generally to medical cannabisIn Committee
• HB5658Compassionate Access to Medical Cannabis Act or Ryan’s Law.Introduced
• SB808Regulating consumable hemp productsIntroduced
• HJR37Amending Constitution to allow for possession, manufacture and sale of cannabisIntroduced
• HB5259Relating to the cultivation of medical cannabisIntroduced
• HB5188Authorizing possession and smoking of medical cannabis by approved personsIntroduced
• HB5100Transferring all regulatory and enforcement responsibilities for CBD and Kratom from the Department of Agriculture to the Alcohol Beverage Control Administration.Introduced
• HB5092Relating to certification of a patient’s eligibility for medical cannabisIntroduced
• HB4371Relating to legalizing cannabis production, sales and adult consumptionIntroduced
• HB4270Relating to authorizing the Department of Agriculture to promulgate a legislative rule relating to select plant-based derivatives and select plant-based derivative products of hemp and kratom.Introduced
• SJR5Cannabis Legalization AmendmentIntroduced